Immunic AG | WebDisclosure

Basculer en Français

10864	Companies
236191	Keywords
165101	Articles
126640	Press releases

Home
Companies
Immunic AG

PRESS RELEASE

published on 05/19/2026 at 12:30, 3 months 2 days ago

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
Immunic appoints Michael W. Bonney as Board Chair, bringing over 30 years of biopharmaceutical experience. Bonney led successful commercialization of Avonex® for MS. Exciting plans for future therapies

Biopharmaceutical Immunic Board Chair Michael W. Bonney Avonex
BRIEF

published on 05/13/2026 at 12:35, 3 months 8 days ago

Immunic, Inc. Reports Key Financial and Strategic Updates for Q1 2026

Immunic, Inc. Multiple Sclerosis Vidofludimus Calcium Q1 2026 Results Biotechnology Funding
BRIEF

published on 05/13/2026 at 12:35, 3 months 8 days ago

Immunic, Inc. publie des mises à jour financières et stratégiques clés pour le premier trimestre 2026

Immunic, Inc. Sclérose En Plaques Vidofludimus Calcium Financement Des Biotechnologies Résultats Du T1 2026
PRESS RELEASE

published on 05/13/2026 at 12:30, 3 months 8 days ago

Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
Immunic, Inc. announces First Quarter 2026 Financial Results and corporate updates including appointment of Michael A. Panzara, M.D., M.P.H. as Chief Medical Officer and progress in ENSURE Trials for MS treatment

Financial Results Corporate Update Immunic Inc. First Quarter 2026 Michael A. Panzara
BRIEF

published on 04/30/2026 at 12:35, 3 months 21 days ago

Immunisé pour participer à des conférences clés en mai

Vidofludimus Calcium Recherche Sur La Sclérose En Plaques Conférences Sur L'immunité Bioéquité Europe Actualités Biotechnologiques
BRIEF

published on 04/30/2026 at 12:35, 3 months 21 days ago

Immunic to Attend Key Conferences in May

Vidofludimus Calcium Multiple Sclerosis Research Immunic Conferences Bio€quity Europe Biotechnology News
PRESS RELEASE

published on 04/30/2026 at 12:30, 3 months 21 days ago

Immunic to Participate in Investor and Medical Conferences in May
Immunic, Inc. (Nasdaq: IMUX) to participate in investor and medical conferences in May to present innovative therapies for neurologic diseases

Investor Conferences Immunic Medical Conferences Novel Therapies Neurologic Diseases
BRIEF

published on 04/28/2026 at 12:35, 3 months 23 days ago

Immunic Appoints Michael A. Panzara as Chief Medical Officer

Chief Medical Officer Immunic Inc. Vidofludimus Calcium Michael A. Panzara Neurology Drug Development
BRIEF

published on 04/28/2026 at 12:35, 3 months 23 days ago

Immunic nomme Michael A. Panzara au poste de directeur médical

Immunic Inc. Vidofludimus Calcium Michael A. Panzara Développement De Médicaments En Neurologie Médecin-chef
PRESS RELEASE

published on 04/28/2026 at 12:30, 3 months 23 days ago

Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer
Immunic appoints Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer, bringing extensive experience in neurology drug development and regulatory approvals. Company transitions into a fully integrated commercial-stage entity

Chief Medical Officer Immunic Neurology Commercial-stage Michael A. Panzara

Accesswire

Published on 08/21/2026 at 02:30, 10 hours 30 minutes ago

PPX Mining Announces Completion of Debt Settlement
Published on 08/21/2026 at 00:00, 13 hours ago

Apex Confirms Favourable Monazite and Bastnaesite Mineralogy at the Rift Rare Earth Project
Published on 08/20/2026 at 23:00, 14 hours ago

EQ Inc. Reports Second Quarter 2026 Financial Results
Published on 08/20/2026 at 22:00, 15 hours ago

Gold Terra Closes Third and Final Tranche of Its LIFE Offering for Gross Proceeds of Approximately C$10.1 M
Published on 08/20/2026 at 15:30, 21 hours 30 minutes ago

Caldwell Announces Promotion of Lindsay Schoen Lane to Partner

View all ACCESSWIRE

EQS Group

Published on 08/21/2026 at 12:27, 32 minutes ago

Brockhaus Technologies AG: Annual General Meeting approves share buyback of up to €90 million and balance-sheet optimization by a clear majority
Published on 08/21/2026 at 12:05, 54 minutes ago

METLEN conducts First Fire on Waste at the Protos ERF plant in Cheshire
Published on 08/21/2026 at 11:46, 1 hour 14 minutes ago

2026 Annual General Meeting: Three Pillars – One Strategy
Published on 08/21/2026 at 11:28, 1 hour 31 minutes ago

EQS-Adhoc: Borussia Dortmund GmbH & Co. KGaA: Borussia Dortmund publishes preliminary figures for the 2025/2026 financial year
Published on 08/21/2026 at 11:28, 1 hour 31 minutes ago

Circus Holds Successful 2026 Annual General Meeting as Global AI Robotics Rollout Progresses

Les Echos

Published on 08/21/2026 at 08:30, 4 hours 30 minutes ago

Thales issues a €1bn bond
Published on 08/21/2026 at 08:30, 4 hours 30 minutes ago

Thales émet un emprunt obligataire de 1 Md€
Published on 08/18/2026 at 18:00, 2 days 19 hours ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 2 days 19 hours ago

Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 3 days 1 hour ago

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026

View all LES ECHOS COMFI WIRE